Human Metabolome Technologies (TSE:6090) Marketable Securities: 円0 Mil (As of Dec. 2025)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

Human Metabolome Technologies Inc TSE:6090

54 GF Score

Price 円592.00

GF Value 円798.54

Valuation Modestly Undervalued

5 Warning Signs

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

What is Human Metabolome Technologies Marketable Securities?

Human Metabolome Technologies TSE:6090 +0.34% 54 Marketable Securities is 円0 Mil as of Dec. 2025. GuruFocus rates TSE:6090 with a GF Score™ of 54/100 and a GF Value™ of 円798.54 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Human Metabolome Technologies's Marketable Securities for the quarter that ended in Dec. 2025 was 円0 Mil.

Try GuruFocus Premium free for 7 days

Unlock GF Score, GF Value, 30-Y financials, and pro screeners.

Get Started →

Human Metabolome Technologies (TSE:6090) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Human Metabolome Technologies Marketable Securities Related Terms

Human Metabolome Technologies Marketable Securities Historical Data

* Premium members only.

The historical data trend for Human Metabolome Technologies's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Human Metabolome Technologies Marketable Securities Chart

Human Metabolome Technologies Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Jun20

Jun21

Jun22

Jun23

Jun24

Marketable Securities

Get a 7-Day Free Trial

100.00

0.00

Human Metabolome Technologies Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Marketable Securities	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

54GF Score

Human Metabolome Technologies Inc TSE:6090

Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

Human Metabolome Technologies Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →

What does a Marketable Securities of 円0 Mil mean?

Human Metabolome Technologies (TSE:6090) has a Marketable Securities of 円0 Mil as of Dec. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Human Metabolome Technologies and its competitors.

Is Human Metabolome Technologies' Marketable Securities too high?

Human Metabolome Technologies' current Marketable Securities is 円0 Mil. Overall, Human Metabolome Technologies has a GF Score™ of 54/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Human Metabolome Technologies' Marketable Securities compare to TMO and DHR?

Human Metabolome Technologies' Marketable Securities of 円0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Marketable Securities for a Medical Diagnostics & Research company?

A good Marketable Securities depends on the Medical Diagnostics & Research industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Marketable Securities mean?

A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Human Metabolome Technologies and its competitors. Human Metabolome Technologies's current Marketable Securities is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Human Metabolome Technologies stock overvalued right now?

Based on GuruFocus' analysis, Human Metabolome Technologies (TSE:6090) is currently considered Modestly Undervalued. The stock's GF Value™ is 円798.54, compared to a current price of 円592.00 — trading 25.9% below its estimated fair value. The current Marketable Securities is 円0 Mil. Human Metabolome Technologies' overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Marketable Securities calculated?

Marketable Securities is calculated from a company's financial statements. For Human Metabolome Technologies (TSE:6090), the current Marketable Securities is 円0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Human Metabolome Technologies (TSE:6090) Overvalued in 2026?

Based on GuruFocus' analysis, Human Metabolome Technologies stock appears to be undervalued. The current stock price of 円592.00 is trading 25.9% below its estimated GF Value™ of 円798.54. GuruFocus considers Human Metabolome Technologies to be Modestly Undervalued.

Key valuation signals for TSE:6090:

Marketable Securities: 円0 Mil
GF Value™: 円798.54 vs. price of 円592.00 (25.9% below fair value)
GF Score™: 54/100 with 5 warning signs

No single metric tells the full story. See the TSE:6090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →